4//SEC Filing
LIEBMAN SEYMOUR 4
Accession 0000899243-21-000325
CIK 0001492674other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:10 PM ET
Size
9.3 KB
Accession
0000899243-21-000325
Insider Transaction Report
Form 4
LIEBMAN SEYMOUR
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-01-01+34,188→ 34,188 total→ Common Stock (34,188 underlying) - Award
Restricted Stock Units
2021-01-01+32,258→ 32,258 total→ Common Stock (32,258 underlying) - Exercise/Conversion
Common Stock
2021-01-01+34,188→ 84,185 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2022.
- [F3]On January 1, 2020 the reporting person was granted 34,188 restricted stock units that vested on January 1, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001252287
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:10 PM ET
- Size
- 9.3 KB